Member Info for MALTBY2002

It would be good to get clarification today on Medusa’s contribution to private sales of our LFD. Some very clever people behind that and they have spent the last 12 months building manufacturing capacity up. Their contribution plus potential licensing agreements could be the real game changer here

Ongoing but slow progress with DHS/PHE.

Very diplomatically put Al. What a bunch of to**ers.

Indeed

In discussions with 20 distributors covering 25 European territories!!

Looking forward to the Presentation

Outstanding results giving us a best in the class test. Great reward for the many of us who had complete faith in Al and the team

He has just said in the Commons that a new Covid test is being developed that can identify whether a position result is of a known variant which could reduce the time taken to identify unknown variants

Results were due at a similar time last year but put back a few weeks because of the placing. Results normally need to be published by 30th June. Like others can’t believe he won’t have the results of the CV out by then as he would be bombarded by questions about it in the Presentation. It does add to the possibility that results may be being delayed by the week of mourning for PP.

Paul Hill talking to Justin Waites on Vox markets today said he puts any potential delay in the CV down to the tardiness of the regulatory authorities and the shortage of potential cases because of the success of the vaccination campaign. He sees the Abcam partnership as further vindication of the superiority of the test. Basically nothing to worry about and be patient

The longer we wait for the CV results the more likely the resulting RNS will contain details of manufacturing capacity both within the UK and beyond and potential contracts both public and private. You wouldn’t want to be out over the weekend!

https://www.gov.uk/guidance/lateral-flow-validation-prioritisation-criteria-for-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens?utm_medium=email&utm_campaign=govuk-notifications&utm_source=de90a72e-c41c-4190-ae45-782a83fe30c7&utm_content=immediately

Updated 6/4

Some people choose to forget that the timing of the LFD CV is dependent on many factors outside Al’s control. This RNS with a world renowned partner could just be the forerunner of a global distribution agreement. Too many people obsessed with the UK market when Al has his sights on Europe and beyond

Further proof of the superiority of our affimer reagent and a nice little starter before the main course

Boris cannot reference a new improved LFD without undermining the present tests as they will have to continue to be used given the numbers the Gov are talking about

Stop moaning and if you have the opportunity and done your research properly then buy some more!

The stupidity of some people posting on this BB today almost beggars belief but thanks for the opportunity to add even more shares at these ridiculously low prices

Looking like a key date when a report on what entry on a plane, pub, restaurant etc will look like. This is likely to include how the testing is likely to look like to gain entry into such places. Should fit into the Avacta timeline

Al must be confident of the forthcoming CV results or indeed had a sneak preview of them to now concentrate the company’s very valuable resources on their LFT. Not derisked yet but not far off

https://t.co/VgyJumcFLK?amp=1

One of Align Research top picks of the year as well

Under 50’s to only get the jab in exceptional circumstances. 2nd jab prioritised

From March 29th which will increase the importance of testing

Breath test under 60 seconds using affimers. Interesting